anxiolytics (Adir)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameanxiolytics (Adir)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor antagonistsSerotonin 2a (5-HT2a) receptor antagonistsDopamine D2 receptor modulators
TargetsSerotonin 2a (5-HT2a) receptorDopamine D2 receptorSerotonin 1a (5-HT1a) receptor
Therapy Area/IndicationsAnxiety Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAdir Sarl
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdir Sarl
Active IndicationsN/A
Inactive IndicationsAnxiety Disorders

Other Information

ATC CodeN/A
Related LinksN/A